Veracyte Inc Revenue per Employee (VCYT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Veracyte Inc   (NASDAQ: VCYT)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Veracyte Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 23.45% in the second quarter 2026, year on year to cumulative value of $545 million, Veracyte Inc 's revenue per employee grew on a trailing twelve months basis to $ 721,503. The productivity of Veracyte Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 130 other companies have achieved higher revenue per employee. While Veracyte Inc 's total ranking has deteriorated compared to the previous quarter from 1106 to 1224. Veracyte Inc has 755 employees.


What is Sales per Employee Ratio?







VCYT Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 23.45 % 24.79 % 32.81 % 15.07 % 16.07 %
Sales per Employee (TTM) $ 721,503 683,686 648,387 603,890 582,338
VCYT's Total Ranking # 1224 # 1106 # 971 # 597 # 1190
Seq. Revenue Change 12.05 % -1.33 % 9.41 % 2.06 % 13.27 %


Revenue per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 131
Overall Market # 1224

Revenue per Employee Statistics
High Average Low
$ 683,686 $ 259,769 $ 50,583
(Mar 31 2026)   (Dec. 30, 2014)



Financial Statements
Veracyte Inc 's Revenue MRQ $ 150 Millions Visit VCYT's Income Statement
Veracyte Inc 's Revenues TTM $ 545 Millions Visit VCYT's aggregate revenue growth
What are VCYT's Sales? Visit VCYT's Sales by Segment




Other Ratios
Veracyte Inc 's Income per Employee
Employees in Medical Laboratories
Medical Laboratories Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VCYT's Revenue per Employee versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VCYT's Competitors
Revenue per Employee for VCYT's Suppliers
Revenue per Employee for VCYT's Customers

You may also want to know
VCYT's Sales Growth Rates VCYT's Pe Price to earnings ratio VCYT's Receivables Turnover Ratio VCYT's Stock Quote
VCYT's Net Income Growth Rates VCYT's Ps Price to Sales ratio VCYT's Sales per Employee VCYT's Asset Turnover Ratio
VCYT's Net Margin VCYT's Pb Price to Book ratio VCYT's Financial Strength Ratios VCYT's Dividend Payout Ratio
Date modified: 2026-09-02T19:45:38+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.